Expert Opinion on Investigational Drugs, Volume 28, Issue 8 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 28, Issue 8 (2019)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Volume 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Drug Evaluation

Article
The NK1 receptor antagonist serlopitant for treatment of chronic pruritus
Sonja Ständer, Mary C. Spellman, Paul Kwon & Gil Yosipovitch
Pages: 659-666
Published online: 04 Jul 2019
AbstractforThe NK1 receptor antagonist serlopitant for treatment of chronic pruritus | Full Text | References | PDF (923.2 KB) | EPUB
  • 3764 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Article
Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer
Erlisa Bardhi, Claudia Marchetti, Annalisa Scopelliti, Lucia Musacchio, Federica Tomao, Michele Schiavi, Carlo Carraro, Innocenza Palaia, Marco Monti, Ludovico Muzii & Pierluigi Benedetti Panici
Pages: 667-673
Published online: 30 Jul 2019
AbstractforEtirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer | Full Text | References | PDF (977 KB) | EPUB
  • 95 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Article
A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations
Hani M Babiker, Lisa Davis, Kristian Larson, Crystal Placencia, Connor Swensen, Pavan Tenneti, Melissa Lim, Ruth Cañamar, Jacqueline Curtis, Erica Castillo, James Mancuso, Diane Rensvold, Sarah Martinez, Lora Macias, Alejandro Recio-Boiles, Sreenivasa R Chandana & Daruka Mahadevan
Pages: 675-686
Published online: 29 Jul 2019
AbstractforA Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations | Full Text | References | PDF (895.7 KB) | EPUB
  • 306 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Experimental and investigational drugs for the treatment of acute otitis media
Nicola Principi & Susanna Esposito
Pages: 687-694
Published online: 10 Jul 2019
AbstractforExperimental and investigational drugs for the treatment of acute otitis media | Full Text | References | PDF (650.3 KB) | EPUB
  • 270 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer
Alvaro H Ingles Garces, Lewis Au, Robert Mason, Jennifer Thomas & James Larkin
Pages: 695-708
Published online: 06 Aug 2019
AbstractforBuilding on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer | Full Text | References | PDF (1.2 MB) | EPUB
  • 617 Views
  • 36 CrossRef citations
  • 0Altmetric
Review
Investigational drugs in early-stage clinical trials for autism spectrum disorder
Michael P. Hong & Craig A. Erickson
Pages: 709-718
Published online: 12 Aug 2019
AbstractforInvestigational drugs in early-stage clinical trials for autism spectrum disorder | Full Text | References | PDF (780.2 KB) | EPUB
  • 504 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
What can independent research for mesothelioma achieve to treat this orphan disease?
Alice Guazzelli, Parisa Meysami, Emyr Bakker, Ezio Bonanni, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti
Pages: 719-732
Published online: 01 Jul 2019
AbstractforWhat can independent research for mesothelioma achieve to treat this orphan disease? | Full Text | References | PDF (1.2 MB) | EPUB
  • 144 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials
Alessio Molfino, Maria Ida Amabile, Antonella Giorgi, Massimo Monti, Vito D’Andrea & Maurizio Muscaritoli
Pages: 733-740
Published online: 26 Jul 2019
AbstractforInvestigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials | Full Text | References | PDF (775.2 KB) | EPUB
  • 493 Views
  • 13 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy
Ava Aghakhani et al.
Review Article | Published online: 30 May 2024
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus
Eric F. Morand et al.
Plain Language Summary of Publication | Published online: 29 May 2024
Open Access
Inflammation and Huntington’s disease – a neglected therapeutic target?
Sophie E. Field et al.
Review Article | Published online: 29 May 2024
Open Access
Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration
Shogo Hashimoto et al.
Review Article | Published online: 29 May 2024
View all latest articles